SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-044232
Filing Date
2013-09-13
Accepted
2013-09-13 19:07:10
Documents
1
Period of Report
2013-09-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 15111
  Complete submission text file 0001209191-13-044232.txt   16608
Mailing Address C/O SPIROS DEVELOPMENT CORP II INC 7475 LUSK BLVD SAN DIEGO CA 92121
Business Address
KABAKOFF DAVID S (Reporting) CIK: 0001024008 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34828 | Film No.: 131097390
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Issuer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences